Aducanumab Completed Phase 1 Trials for Healthy Volunteers (HV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04924140A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers
NCT05216887A Study to Assess the Pharmacokinetic (PK) Comparability of 2 Fixed Subcutaneous (SC) Doses of Aducanumab (BIIB037) With a Single, Weight-Based Intravenous (IV) Dose in Healthy Volunteers